Invesco Ltd. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 152 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$939,000
+30.4%
155,673
-22.1%
0.00%
Q3 2019$720,000
+68.2%
199,928
+25.2%
0.00%
Q2 2019$428,000
-12.5%
159,678
-3.3%
0.00%
Q1 2019$489,000
+61.9%
165,160
-12.9%
0.00%
Q4 2018$302,000
-42.3%
189,730
+33.4%
0.00%
Q3 2018$523,000
+52.9%
142,191
+17.5%
0.00%
Q2 2018$342,000
-23.0%
121,022
+1.2%
0.00%
Q1 2018$444,000
+56.9%
119,578
+21.5%
0.00%
Q4 2017$283,000
-31.3%
98,399
+7.2%
0.00%
Q3 2017$412,000
-0.7%
91,788
+1.5%
0.00%
Q2 2017$415,000
+7.8%
90,441
-1.2%
0.00%
Q1 2017$385,000
-94.1%
91,533
-88.6%
0.00%
-100.0%
Q3 2016$6,479,000
+7.0%
799,847
+3.0%
0.00%0.0%
Q2 2016$6,054,000
-24.4%
776,193
-25.2%
0.00%
-33.3%
Q1 2016$8,009,000
-34.1%
1,037,451
-7.9%
0.00%
-40.0%
Q4 2015$12,154,000
+14904.9%
1,126,449
+9557.5%
0.01%
Q3 2015$81,000
+138.2%
11,664
+202.6%
0.00%
Q2 2015$34,000
-99.8%
3,855
-99.8%
0.00%
-100.0%
Q1 2015$17,027,000
-1.3%
1,726,836
+22.7%
0.01%0.0%
Q4 2014$17,245,000
+34.3%
1,407,760
+9.4%
0.01%
+40.0%
Q3 2014$12,841,000
+266.9%
1,286,673
+178.3%
0.01%
+400.0%
Q2 2014$3,500,000462,3970.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders